Events

Optimising Orphan Drug Development Tailor a specific approach for orphan drug product development across various rare disease classifications and optimise the commercial aspects 15-16 Nov 2010: Brussels, Belgium 10 years on since the introduction of the EU Orphan Medicinal Products Regulation policy makers are reviewing these with a time limit...
Centric Health Resources Presents Third Annual Ultra Orphan Conference 2010, “Emerging Commercialization Strategies for Addressing the Needs of Ultra- Orphan Patients” September 27 – 29, 2010, The Westin Hotel, St. Louis, Mo. Invitation Only Event. Complimentary Registration. Limited Seating. (http://www.centrichealthresources.com/2010Conference/)  CHESTERFIELD, Mo. – August 11, 2010 – With orphan drug...
The conference brings together public health professionals to encourage the exchange of scientific and public health information on global emerging infectious disease issues. The International Conference on Emerging Infectious Diseases was first convened in 1998; ICEID 2010 marks its seventh occurence. The conference brings together public health professionals to encourage...
There has been a significant increase in the level of activity and attention being paid to the development of therapeutics for neglected diseases over the past five years, but there are still considerable challenges in the road ahead. Diseases in the developed world receive a disproportional investment because of the...
Encephalitis Global, Inc. is happy to invite FACES (Friends And Caregivers, Encephalitis Survivors) to join in a social event in Portland Oregon. This is our 8th annual Encephalitis Conference! Similar to our FACES 2007 in Nashville, this year’s FACES is a get together. No meetings, no speakers, no registration fee,...
Current gaps in knowledge in this area will be identified and research priorities will be formulated. The workshop summary will provide the National Institute of Allergy and Infectious Diseases (NIAID) and the scientific community a template to address the scientific and clinical issues related to this difficult area of neonatal...
Anticipated goals and use of results: Workshop participants will have an unprecedented opportunity to synthesize relevant functional, experimental, and human data on MYC-translocation to gain etiologic insight and provide direction for further research.
Presenting new developments in basic and clinical science to bear on the specific issues of Behçet Disease (BD). Topics to be covered will include immunology of BD, vasculitis in BD, genetic basis of BD, regional inflammation and paediatric BD. The programme will also include debates on topics of current interest...
This year’s event – Measures of Progress – Evaluating management outcome in childhood disability – will update and clarify the multidimensional model of disablement specifically applied to management of children with neurodevelopmental disability. Emphasis is on the need for reliable measurement of management outcomes through new findings, from functional imaging...
The goals of the 2010 Workshop is to provide a platform that will assemble clinicians and scientists, integrate their findings, and facilitate new directions within both clinical and basic science research. The main focus is to bring basic and clinical scientists together to promote collaboration and progress in Progeria research....
Forge Valuable Patient Advocacy and Access Alliances throughout Orphan Drug Development and Commercialization Each year, CBI works collaboratively with NORD to develop a summit in support of a common goal to serve the rare disease community. Building off of a successful four-year history, this summit assembles industry stakeholders and key...
The goals of the Opsoclonus Myoclonus Syndrome (OMS) Workshop are to discuss the various issues and special challenges that are associated with the diagnosis, prognosis, and treatment of OMS. The objective is to identify strategies to improve research and clinical collaborations and resource sharing in the United States and internationally....
The outcomes of this conference will foster the basic mission of the NIH/NIDCR by providing new knowledge to improve the oral, dental, craniofacial, and bone health of our nation through high-quality research, facilitation of interactions and collaborations by scientists across multiple fields related to mineralization, providing networking and training to...
The goal of this conference is to establish research priorities and encourage the development of research collaborations. It is expected that criteria for diagnosing and monitoring rare diseases, including newborn screening, will be advanced and that the information exchanges at this conference will facilitate new discoveries and new scientific publications....
We expect to bring together scientists interested in making as much information available for addressing the causes and possible remedies of AGS by describing how the RNase H2 works, particularly how defects in activity and/or stability can be addressed.
Studies on the sinusoidal cells are becoming increasingly important in diverse areas ranging from stem cells, liver development and regeneration, and the pathogenesis of liver diseases such as steatohepatitis, fibrosis, and HCC to therapeutic approaches including liver transplantation. The target audience is both established and junior investigators, graduate students, and...